Pseudolaric Acid B Inhibits Proliferation, Invasion and Epithelial-to-Mesenchymal Transition in Human Pancreatic Cancer Cell
- Author:
Xiaoyu LI
1
;
Xianzhi ZHAO
;
Wen SONG
;
Zibin TIAN
;
Lin YANG
;
Qinghui NIU
;
Qi ZHANG
;
Man XIE
;
Bin ZHOU
;
Yonghong XU
;
Jun WU
;
Cuiping ZHANG
Author Information
- Publication Type:Original Article
- Keywords: PAB; PDAC; EMT; cell proliferation; Hippo-YAP pathway
- MeSH: Animals; Antineoplastic Agents/pharmacology; Antineoplastic Agents/therapeutic use; Biomarkers, Tumor/metabolism; Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation/drug effects; Cytokines; Deoxycytidine/analogs & derivatives; Deoxycytidine/pharmacology; Deoxycytidine/therapeutic use; Diterpenes/pharmacology; Diterpenes/therapeutic use; Epithelial-Mesenchymal Transition/drug effects; Female; Humans; Mice, Nude; Neoplasm Invasiveness; Pancreatic Neoplasms/diet therapy; Pancreatic Neoplasms/pathology; Real-Time Polymerase Chain Reaction; Signal Transduction/drug effects; Vimentin/metabolism
- From:Yonsei Medical Journal 2018;59(1):20-27
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: This study was aimed to investigate the effect of pseudolaric acid B (PAB) on proliferation, invasion and epithelial-to-mesenchymal transition (EMT) in pancreatic cancer cells and to explore the possible mechanism. MATERIALS AND METHODS: The pancreatic cancer cell line SW1990 was cultured and treated with PAB dose- and time-dependent manners. Cell proliferation and invasion ability were measured by MTT assay and Matrigel/Transwell test, respectively. Semi-quantitative real-time polymerase chain reaction and Western blotting were conducted to detect the expression of EMT markers and the key molecules. Finally, nude mice subcutaneous transplantation tumor model was used to confirm the therapy efficacy of PAB. RESULTS: PAB could inhibit SW1990 cell proliferation and invasion in time- and dose-dependent manners. Vimentin, fibronectin, N-cadherin, Snail, Slug, YAP, TEAD1, and Survivin were down-regulated (p < 0.01), while E-cadherin, caspase-9, MST1, and pYAP were up-regulated (p < 0.05). Combined PAB and gemcitabine treatment markedly restricted the tumor growth compared with gencitabin or PAB alone groups. CONCLUSION: PAB could inhibit the proliferation and invasion ability of pancreatic cancer cells through activating Hippo-YAP pathway and inhibiting the process of EMT.
